| Immune response_Complement pathway |
3.95E-10 |
| Immune response_IL-17 signaling pathways |
3.27E-07 |
| Cell adhesion_Chemokines and adhesion |
1.99E-03 |
| Cell adhesion_Cell-matrix glycoconjugates |
4.14E-03 |
| Cell adhesion_ECM remodeling |
7.65E-03 |
| Inflammation_Complement system |
2.93E-06 |
| Immune response_Th17-derived cytokines |
1.25E-05 |
| Proteolysis_ECM remodeling |
2.47E-03 |
| Immune response_Phagocytosis |
5.17E-03 |
| Proteolysis_Connective tissue degradation |
6.38E-03 |
| Inflammation_Innate inflammatory response |
2.02E-02 |
| Cell adhesion_Cell-matrix interactions |
3.04E-02 |
| Rupture |
5.07E-13 |
| Encephalomyelitis, Autoimmune, Experimental |
1.71E-12 |
| Nervous System Autoimmune Disease, Experimental |
1.71E-12 |
| Cicatrix, Hypertrophic |
3.39E-11 |
| Hemolytic-Uremic Syndrome |
2.44E-10 |
| Encephalomyelitis |
4.54E-10 |
| Polycystic Ovary Syndrome |
7.06E-10 |
| Central Nervous System Infections |
8.67E-10 |
| Inflammation |
8.99E-10 |
